SCHEMBL13532215

SCHEMBL13532215

CC(C)=CCC/C(C)=C\Cc1c2occc2c(O)c2ccc(=O)oc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 4/20 0.57
▸ VKORC1 Q9BQB6 1/20 0.52
▸ CYP3A4 P08684 3/20 0.51
▸ TDP1 Q9NUW8 3/20 0.51
▸ ALOX15 P16050 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ ALOX5 P09917 1/20 0.51
▸ CYP2E1 P05181 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ CYP2B6 P20813 1/20 0.51
▸ CYP3A5 P20815 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945593 0.90 PDE4D (0.55) BACE1VKORC1CYP3A4KDM4EALDH1A1
SCHEMBL6272567 0.77 MAOA (0.54) BACE1VKORC1CYP3A4KDM4EALDH1A1
SCHEMBL29740208 0.77 CYP1B1 (0.69) BACE1CYP3A4ALOX15KDM4EALDH1A1
SCHEMBL16352046 0.77 CYP1B1 (0.69) BACE1CYP3A4ALOX15KDM4EALDH1A1
SCHEMBL13532216 0.76 PDE4D (0.67) BACE1CYP3A4KDM4EALDH1A1ALOX5
SCHEMBL3179673 0.76 PDE4D (0.67) BACE1CYP3A4KDM4EALDH1A1ALOX5
SCHEMBL24075636 0.75 MAOA (0.78) BACE1VKORC1CYP3A4TDP1ALOX15
SCHEMBL30158338 0.75 MAOA (0.78) BACE1VKORC1CYP3A4TDP1ALOX15
SCHEMBL1714349 0.71 CYP1B1 (0.43) BACE1CYP3A4TDP1ALOX15KDM4E
SCHEMBL16768172 0.69 VKORC1 (0.97) VKORC1CYP3A4ALOX15ALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016419-A1 ANTIBACTERIAL COMPOSITION TAKEUCHI RYO 2010-01-21 — — US disclosed
US-20100016419-A1 ANTIBACTERIAL COMPOSITION TAKEUCHI RYO 2010-01-21 — — US disclosed
EP-1788878-B1 ANTIBACTERIAL COMPOSITION TAKASAGO PERFUMERY CO LTD (JP) 2008-10-15 — — EP disclosed
US-20080096958-A1 Antibacterial Composition TAKEUCHI RYO 2008-04-24 — — US disclosed
US-20080096958-A1 Antibacterial Composition TAKEUCHI RYO 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096958-A1 Antibacterial Composition SPOUT1, NOP2, CASP7 BACE1 1068/4885VKORC1 3639/4885CYP3A4 1091/4885
US-20100016419-A1 ANTIBACTERIAL COMPOSITION SPOUT1, CASP7, NOP2 BACE1 1118/4885VKORC1 3647/4885CYP3A4 1055/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback